Biofrontera Inc. (BFRI)
NASDAQ: BFRI · Real-Time Price · USD
1.000
-0.090 (-8.26%)
Nov 4, 2024, 4:00 PM EST - Market closed
Biofrontera Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Revenue | 35.24 | 34.07 | 28.67 | 24.1 | 18.85 | 26.18 |
| Revenue Growth (YoY) | 21.33% | 18.82% | 18.98% | 27.86% | -28.01% | - |
| Cost of Revenue | 18.42 | 17.44 | 15.19 | 12.74 | 9.07 | 12.41 |
| Gross Profit | 16.82 | 16.63 | 13.49 | 11.36 | 9.78 | 13.77 |
| Selling, General & Admin | 34.95 | 37.9 | 35 | 25.96 | 18.12 | 28.4 |
| Research & Development | 0.7 | 0.08 | - | - | - | - |
| Operating Expenses | 35.65 | 37.98 | 35 | 25.96 | 18.12 | 28.4 |
| Operating Income | -18.83 | -21.35 | -21.51 | -14.6 | -8.33 | -14.62 |
| Interest Expense | -2.43 | -0.6 | -0.37 | -0.36 | -2.9 | -2.16 |
| Interest & Investment Income | 0.07 | 0.13 | 0.18 | 0.02 | 0.03 | 0.03 |
| Currency Exchange Gain (Loss) | -0.11 | -0.11 | -0.03 | - | - | - |
| Other Non Operating Income (Expenses) | 3.81 | 3.04 | 16.36 | -12.65 | 0.08 | 0.18 |
| EBT Excluding Unusual Items | -17.49 | -18.89 | -5.38 | -27.6 | -11.12 | -16.58 |
| Merger & Restructuring Charges | - | - | - | -0.75 | -1.13 | -3.53 |
| Gain (Loss) on Sale of Investments | -3.01 | -7.42 | 1.75 | - | - | - |
| Gain (Loss) on Sale of Assets | - | - | - | - | - | -0.59 |
| Legal Settlements | 7.39 | 6.16 | -0.87 | -11.25 | - | - |
| Other Unusual Items | -0.38 | 0.03 | 3.89 | 1.94 | 1.33 | 9.75 |
| Pretax Income | -13.5 | -20.12 | -0.61 | -37.66 | -10.92 | -10.95 |
| Income Tax Expense | 0.02 | 0.01 | 0.03 | 0.06 | 0.06 | 0.03 |
| Net Income | -13.51 | -20.13 | -0.64 | -37.71 | -10.99 | -10.98 |
| Net Income to Common | -13.51 | -20.13 | -0.64 | -37.71 | -10.99 | -10.98 |
| Shares Outstanding (Basic) | 3 | 2 | 1 | 0 | - | - |
| Shares Outstanding (Diluted) | 3 | 2 | 1 | 0 | - | - |
| Shares Change (YoY) | 136.47% | 46.29% | 140.00% | - | - | - |
| EPS (Basic) | -4.44 | -13.02 | -0.61 | -85.63 | - | - |
| EPS (Diluted) | -4.44 | -13.02 | -0.61 | -85.63 | - | - |
| Free Cash Flow | -18.92 | -24.9 | -16.24 | -26.73 | -12.37 | -38.22 |
| Free Cash Flow Per Share | -6.21 | -16.10 | -15.36 | -60.68 | - | - |
| Gross Margin | 47.74% | 48.80% | 47.04% | 47.13% | 51.90% | 52.61% |
| Operating Margin | -53.42% | -62.67% | -75.02% | -60.59% | -44.21% | -55.85% |
| Profit Margin | -38.34% | -59.09% | -2.23% | -156.49% | -58.29% | -41.95% |
| Free Cash Flow Margin | -53.67% | -73.08% | -56.63% | -110.90% | -65.62% | -145.96% |
| EBITDA | -18.32 | -20.85 | -20.99 | -14.06 | -7.77 | -13.96 |
| EBITDA Margin | -51.97% | -61.19% | -73.21% | -58.34% | -41.23% | -53.30% |
| D&A For EBITDA | 0.51 | 0.5 | 0.52 | 0.54 | 0.56 | 0.67 |
| EBIT | -18.83 | -21.35 | -21.51 | -14.6 | -8.33 | -14.62 |
| EBIT Margin | -53.42% | -62.67% | -75.02% | -60.59% | -44.21% | -55.85% |
| Revenue as Reported | 35.24 | 34.07 | 28.67 | 24.1 | 18.85 | 26.18 |
| Advertising Expenses | - | 0.2 | 0.1 | 0.5 | - | - |
Source: S&P Capital IQ. Standard template. Financial Sources.